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Abstract
Remitting Seronegative Symmetrical Synovitis with Pitting oedema syndrome, a rare inflammatory
arthritis, commonly affects people in the older age group. It can present as an acute onset
polyarthritis with associated pitting oedema of the extremities. Patients show excellent response
to low dose steroids with complete and sustained remissions. It can also be a paraneoplastic
manifestation of an underlying occult malignancy, hence thorough clinical evaluation is warranted.
We discuss a case of Remitting Seronegative Symmetrical Synovitis with pitting oedema syndrome
where the patient presented with acute onset polyarthritis and pitting oedema of the extremities
without an underlying systemic cause. Patient showed dramatic response to low dose steroids.
Introduction
Remitting Seronegative Symmetrical Synovitis with Pit-
ting oedema (RS3PE) syndrome, a subset of acute onset
polyarthritis mainly affects the older people and predom-
inantly males with clinical manifestations of acute onset
pitting oedema of the hands. Other notable features
include seronegativity for Rheumatoid factor and an
excellent response to low dose steroids with long-term
remission.
In 1985, McCarty et al. [1] described the first case of
Remitting Seronegative Symmetrical Synovitis with Pit-
ting Oedema (RS3PE) syndrome characterized by sym-
metrical distal synovitis and tenosynovitis of the mucous
sheaths of the flexor and extensor tendons of the hands
associated with pitting oedema of the hands and/or feet.
In this case report we discuss a case of RS3PE syndrome
where the initial presentation was bilateral pitting
oedema of the extremities without any other systemic
cause. Patient showed dramatic response to low dose ster-
oids.
Case presentation
A 67-year-old male Caucasian patient was admitted with
a 2-week history of painful swollen hands and painful
knees associated with worsening mobility. This was pre-
ceded by a history of swinging low-grade pyrexia for two
months and a history of progressive pedal oedema for 4
months. The symptoms were atraumatic in onset and
lacked any associated features of connective tissue disease.
There was a positive past medical history of systemic
hypertension, hypothyroidism, diabetes mellitus, chronic
renal failure and Parkinsons disease. The patient had been
treated for carcinoma of the prostate gland in the past.
Examination revealed bilateral pitting oedema of dorsum
of hands and legs upto the calves. He also had synovitis at
proximal interphalangeal joints, wrists and effusion of
both knees and ankles. Initial blood test showed haemo-
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globin of 9.5 g/l with normochromic and nomocytic
anaemia, raised inflammatory markers (ESR 70, CRP 100)
and normal WBC. Autoantibody screen and rheumatoid
factor were negative. Radiological findings of hands, feet
and knees did not show any erosions. The patient was also
screened and investigated for associated malignancies. He
had normal tumour markers including CEA, AFP, CA19-9
and PSA (Prostrate specific antigen). CT thorax/abdomen
and OGD were also reported as normal. In view of low-
grade pyrexia, possibility of infective focus was ruled out
by repeated blood and urine cultures. A diagnosis of
remitting symmetrical seronegative synovitis with pedal
oedema was suggested and patient responded extremely
well to low dose prednisolone at 7.5 mg daily dosage. Fur-
ther follow up 8 weeks later on tapering dose of pred-
nisolone showed complete resolution of signs and
symptoms without any further flare-ups.
Discussion
In 1985, Mc Carty [1] described first RS3PE syndrome in
a series of 10 patients. Following a retrospective multi-
center study of patients Olive et al. [2] proposed the fol-
lowing diagnostic criteria for this syndrome:
1. Bilateral pitting oedema of both hands
2. Sudden onset of polyarthritis
3. Age more than 50 years
4. Seronegative rheumatoid factor.
The exact incidence and prevalence are not known. RS3PE
affects more men than women with ratio of 2:1 and more
frequently the older people.
The aetiology and the pathogenic mechanisms are not
clear. The syndrome was reported to be associated with
HLA B7 [1] and HLA A2 haplotype [3].
Recently, vascular endothelial growth factor (VEGF) has
been implicated as a contributing factor for pathological
changes responsible for both hypervascularity (synovitis)
and vascular permeability (subcutaneous oedema) [4].
Aetiology of pitting oedema is not known, but recent MRI
studies suggest that marked extensor tenosynovitis is the
principle lesion responsible for oedema of subcutaneous
and peritendinous soft tissue [5].
Fever and asthenia could be non-specific manifestations
of inflammation, but presence of other systemic signs like
weight loss, anorexia and poor response to steroids could
indicate a paraneoplastic manifestation.
Evaluation for pedal oedema should aim at ruling out the
other possibilities like congestive cardiac failure, nephritic
syndrome and hypothyroidism.
In older people it is important to distinguish this syn-
drome from PMR (Polymyalgia Rheumatica) in view of
the duration of treatment with steroids that is needed.
This is even more pertinent in view of the long-term con-
sequences of the use of steroids in older people, as these
patients are more likely to be already having multiple co
morbid factors like osteoporosis, hypertension, diabetes
and heart failure. RS3PE syndrome can be associated with
both solid tumours like gastric [6], pancreatic [7] and hae-
matological malignancies like non-hodgkin's lymphoma
[8].
Patients with idiopathic RS3PE showed an excellent
response to low doses of corticosteroids compared to the
poor response to RS3PE in association with neoplasia [9].
Clinicians need to be aware of the RS3PE in ageing popu-
lation and initiate appropriate investigations to exclude
any occult malignancy. The search for occult malignancy
is particularly crucial in patients whose systemic symp-
toms are prominent and who are still not responsive to
steroids.
The main differential diagnosis of RS3PE is polymyalgia
rheumatica, which can be very difficult in older people.
The features helpful in differentiating the two can be seen
in Table 1.
Other differential diagnosis with RS3PE in older people
includes Rheumatoid arthritis, late onset spondyloar-
thropathy, mixed connective tissue disease, chondrocalci-
nosis and amyloid arthropathy.
Blood tests may typically demonstrate raised inflamma-
tory markers, discrete inflammatory anaemia, and a nega-
tive rheumatoid factor. X-rays of the hands and wrists may
show soft tissue swelling but absence of erosions is classic.
Tenosynovitis of both flexor and extensor tendons at the
wrist and the extensor tendons of the feet is the hallmark
of RS3PE. Ultrasonograph a reliable and cost effective
modality for evaluation of patients with suspected RS3PE
this characteristically shows tenosynovitis of flexor and
extensor tendons [10].
MRI is useful for monitoring the disease activity in RS3PE
syndrome. It can also provide information about soft tis-
sue, cartilage and bony erosions [11].
Whole body Ga-67 scan can show increased uptake in
hands and feet and this could be useful in assessing lesionCases Journal 2008, 1:132 http://www.casesjournal.com/content/1/1/132
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activity [12]. Importantly appropriate investigations need
to be carried out if there is any suspicion of malignancy.
Nonsteroidal anti-inflammatory drugs or Salicylates for
pain relief. Most of the patients respond very well to low
dose of steroids (10–15 mg prednisolone) and these
patients show sustained and complete remission even
after withdrawal of steroids. Some patients respond to
hydroxyl chloroquine or gold salts.
Conclusion
RS3PE is a definite syndrome, subset of polyarthritis with
favourable outcome and has a good prognosis in the older
patients. It may present, as a paraneoplastic manifestation
especially in older people who show a poor response to
steroids. If suspected, looking for underlying malignancy
is recommended.
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Table 1: Differentiating features of RS3PE Syndrome and PMR
RS3PE Syndrome PMR
Dramatic response to low dose steroids or NSAIDS and sometimes to 
hydroxychloroquine.
Responds only to steroids
Common in males More frequent in females
Mainly involves wrist with pitting oedema. Involves shoulder and pelvic girdle with associated systemic symptoms. 
Pitting oedema present rarely.
Association with HLA-B7, B27, A2 HLA association with HLA-DR4
Excellent long-term prognosis Frequent relapses and recurrences.Publish with BioMed Central    and   every 
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